Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 16/20 | 0.64 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.54 |
| ▸ | USP36 | Q9P275 | 1/20 | 0.53 |
| ▸ | RET | P07949 | 1/20 | 0.51 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.51 |
| ▸ | KIT | P10721 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.51 |
| ▸ | FLT1 | P17948 | 1/20 | 0.51 |
| ▸ | FLT4 | P35916 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | FRK | P42685 | 1/20 | 0.51 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.51 |
| ▸ | LDHA | P00338 | 1/20 | 0.51 |
| ▸ | LDHB | P07195 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13339854 | 0.89 | CSF1R (0.77) | CSF1RRETPDGFRBKITSRC | |
| SCHEMBL20100909 | 0.88 | CSF1R (0.72) | CSF1RRETPDGFRBKITSRC | |
| SCHEMBL18023935 | 0.87 | CSF1R (0.59) | CSF1RKDRLDHALDHBMEN1 | |
| SCHEMBL20100905 | 0.86 | CSF1R (0.68) | CSF1RRPS6KB1USP36RETPDGFRB | |
| SCHEMBL18023962 | 0.85 | CSF1R (0.86) | CSF1RRPS6KB1USP36RETPDGFRB | |
| SCHEMBL13339849 | 0.84 | CSF1R (0.75) | CSF1RRETPDGFRBKITSRC | |
| SCHEMBL13340361 | 0.84 | CSF1R (0.73) | CSF1RRPS6KB1RETPDGFRBKIT | |
| SCHEMBL13340426 | 0.83 | CSF1R (0.72) | CSF1RRPS6KB1RETPDGFRBKIT | |
| SCHEMBL19447191 | 0.83 | CSF1R (0.71) | CSF1RRPS6KB1USP36RETPDGFRB | |
| SCHEMBL17954640 | 0.82 | CSF1R (0.73) | CSF1RRPS6KB1RETPDGFRBKIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3054937-B1 | SPRAY DRY FORMULATIONS | PULMOKINE INC (US) | 2023-07-26 | — | — | EP | disclosed |
| US-20160235742-A1 | SPRAY DRY FORMULATIONS | GILEAD SCIENCES, INC. | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160235742-A1 | SPRAY DRY FORMULATIONS | FLT1, KDR, ERBB2 | CSF1R 169/4885RPS6KB1 911/4885USP36 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.